MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
2.120
-0.110 (-4.93%)
Nov 21, 2024, 3:49 PM EST - Market open
MAIA Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 8.69 | 7.15 | 10.95 | 10.57 | 0.66 | 1.71 |
Cash & Short-Term Investments | 8.69 | 7.15 | 10.95 | 10.57 | 0.66 | 1.71 |
Cash Growth | 42.36% | -34.70% | 3.56% | 1493.82% | -61.19% | - |
Other Receivables | 0.05 | 0.14 | 0.3 | 0.04 | - | - |
Receivables | 0.05 | 0.14 | 0.3 | 0.04 | - | - |
Prepaid Expenses | 0.5 | 0.27 | 0.55 | 0.05 | 0.08 | 0.02 |
Total Current Assets | 9.24 | 7.56 | 11.81 | 10.67 | 0.75 | 1.73 |
Long-Term Deferred Charges | - | - | 0.21 | 0.65 | - | - |
Other Long-Term Assets | 0 | 0 | 0 | 0 | - | - |
Total Assets | 9.24 | 7.57 | 12.02 | 11.33 | 0.75 | 1.73 |
Accounts Payable | 1.15 | 1.64 | 1.17 | 0.96 | 0.15 | 0.17 |
Accrued Expenses | 2.46 | 3.3 | 2.1 | 1.19 | 1.51 | 0.18 |
Short-Term Debt | - | - | - | - | 0.02 | 0.03 |
Current Portion of Long-Term Debt | - | - | - | - | 0.01 | - |
Other Current Liabilities | - | - | - | - | - | 0 |
Total Current Liabilities | 3.61 | 4.94 | 3.27 | 2.15 | 1.69 | 0.37 |
Long-Term Debt | - | - | - | - | 0.43 | 0.01 |
Other Long-Term Liabilities | 4.02 | 2.15 | 0.25 | - | 0.24 | 0.03 |
Total Liabilities | 7.62 | 7.09 | 3.51 | 2.15 | 2.36 | 0.41 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 85.29 | 64.47 | 52.73 | 37.62 | 12.6 | 9.23 |
Retained Earnings | -83.66 | -63.98 | -44.21 | -28.44 | -15.93 | -9.3 |
Comprehensive Income & Other | -0.01 | -0.02 | -0.02 | - | -0 | -0.1 |
Total Common Equity | 1.62 | 0.48 | 8.51 | 9.18 | -3.34 | -0.17 |
Minority Interest | - | - | - | - | 1.72 | 1.5 |
Shareholders' Equity | 1.62 | 0.48 | 8.51 | 9.18 | -1.62 | 1.32 |
Total Liabilities & Equity | 9.24 | 7.57 | 12.02 | 11.33 | 0.75 | 1.73 |
Total Debt | - | - | - | - | 0.46 | 0.03 |
Net Cash (Debt) | 8.69 | 7.15 | 10.95 | 10.57 | 0.2 | 1.68 |
Net Cash Growth | 42.36% | -34.70% | 3.56% | 5195.01% | -88.08% | - |
Net Cash Per Share | 0.44 | 0.54 | 1.18 | 2.00 | 0.05 | 0.44 |
Filing Date Shares Outstanding | 25.33 | 20 | 11 | 7.94 | 4.43 | 3.77 |
Total Common Shares Outstanding | 23.97 | 16.99 | 10.96 | 7.58 | 4.43 | 3.77 |
Working Capital | 5.63 | 2.63 | 8.54 | 8.53 | -0.95 | 1.36 |
Book Value Per Share | 0.07 | 0.03 | 0.78 | 1.21 | -0.75 | -0.05 |
Tangible Book Value | 1.62 | 0.48 | 8.51 | 9.18 | -3.34 | -0.17 |
Tangible Book Value Per Share | 0.07 | 0.03 | 0.78 | 1.21 | -0.75 | -0.05 |
Source: S&P Capital IQ. Standard template. Financial Sources.